These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25457475)

  • 41. What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?
    Cansu GB; Cansu DÜ; Taşkıran B; Bilge ŞY; Bilgin M; Korkmaz C
    Clin Biochem; 2019 May; 67():33-39. PubMed ID: 30914158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Parsimonious Description of Glucose Variability in Type 2 Diabetes by Sparse Principal Component Analysis.
    Fabris C; Facchinetti A; Fico G; Sambo F; Arredondo MT; Cobelli C;
    J Diabetes Sci Technol; 2015 Jul; 10(1):119-24. PubMed ID: 26232371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions.
    Freckmann G; Schauer S; Beltzer A; Waldenmaier D; Buck S; Baumstark A; Jendrike N; Link M; Zschornack E; Haug C; Pleus S
    J Diabetes Sci Technol; 2024 Mar; 18(2):407-413. PubMed ID: 35876145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The northeast glucose drift: Stratification of post-breakfast dysglycemia among predominantly Hispanic/Latino adults at-risk or with type 2 diabetes.
    Barua S; Sabharwal A; Glantz N; Conneely C; Larez A; Bevier W; Kerr D
    EClinicalMedicine; 2022 Jan; 43():101241. PubMed ID: 34988413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A New Stochastic Approach for Modeling Glycemic Disturbances in Type 2 Diabetes.
    Clausen H; Knudsen T; Al Ahdab M; Aradottir T; Schmidt S; Norgaard K; Leth J
    IEEE Trans Biomed Eng; 2021 Oct; 68(10):3161-3172. PubMed ID: 33881986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The dawn phenomenon in non-insulin-dependent diabetes].
    Grimaldi A; Bosquet F; Coutarel P; Thervet F
    Presse Med; 1985 Jul; 14(27):1473. PubMed ID: 3161064
    [No Abstract]   [Full Text] [Related]  

  • 47. Mathematical Models of Meal Amount and Timing Variability With Implementation in the Type-1 Diabetes Patient Decision Simulator.
    Camerlingo N; Vettoretti M; Del Favero S; Facchinetti A; Sparacino G
    J Diabetes Sci Technol; 2021 Mar; 15(2):346-359. PubMed ID: 32940087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium.
    Khalil OS
    Diabetes Technol Ther; 2004 Oct; 6(5):660-97. PubMed ID: 15628820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Machine Learning-based Meal Detection Using Continuous Glucose Monitoring on Healthy Participants: An Objective Measure of Participant Compliance to Protocol.
    Palacios V; Woodbridge DM; Fry JL
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():7032-7035. PubMed ID: 34892722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes: Breakfast most important meal of the day, especially for patients with T2DM.
    Geach T
    Nat Rev Endocrinol; 2015 Oct; 11(10):566. PubMed ID: 26284449
    [No Abstract]   [Full Text] [Related]  

  • 51. Feasibility of Early Meal Detection Based on Abdominal Sound.
    Kolle K; Fougner AL; Ellingsen R; Carlsen SM; Stavdahl O
    IEEE J Transl Eng Health Med; 2019; 7():3300212. PubMed ID: 32309058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dawn phenomenon: variability in occurrence may cause need for change in treatment strategy.
    Zimmerman R
    Endocr Pract; 2014 Dec; 20(12):1352-3. PubMed ID: 25297670
    [No Abstract]   [Full Text] [Related]  

  • 53. Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813-820.
    Abdul-Ghani M; DeFronzo RA; Del Prato S; Chilton R; Singh R; Ryder REJ
    Diabetes Care; 2017 Nov; 40(11):1606. PubMed ID: 28887407
    [No Abstract]   [Full Text] [Related]  

  • 54. The dawn of prospective pharmacogenetic testing in type 2 diabetes.
    Florez JC
    Curr Diab Rep; 2009 Apr; 9(2):95-7. PubMed ID: 19323951
    [No Abstract]   [Full Text] [Related]  

  • 55. Guest Editorial: New dawn or false dawn? – what are the challenges in implementing Localities?
    Tenbensel T
    J Prim Health Care; 2022 Sep; 14(3):197-199. PubMed ID: 36178837
    [No Abstract]   [Full Text] [Related]  

  • 56. The dawn of illness: importance of the pre-diagnostic phase.
    Schattner A
    QJM; 2023 Jun; 116(6):413-414. PubMed ID: 36355471
    [No Abstract]   [Full Text] [Related]  

  • 57. Practice spotlight: dawn dalen.
    Dalen D
    Can J Hosp Pharm; 2009 Sep; 62(5):415-6. PubMed ID: 22478925
    [No Abstract]   [Full Text] [Related]  

  • 58. Rhapsody of Dawn.
    Sheehan G
    Phys Sportsmed; 1981 Dec; 9(12):41. PubMed ID: 27452704
    [No Abstract]   [Full Text] [Related]  

  • 59. Commentary on "Mediation Analysis and Categorical Variables: The Final Frontier" by Dawn Iacobucci.
    Mackinnon DP; Cox MC
    J Consum Psychol; 2012 Oct; 22(4):600-602. PubMed ID: 23180961
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.